Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 2/20 | 0.63 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.63 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.63 |
| ▸ | EGFR | P00533 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23219396 | 1.00 | SLC16A3 (0.63) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 | |
| SCHEMBL11965432 | 1.00 | SLC16A3 (0.63) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 | |
| SCHEMBL15128919 | 1.00 | SLC16A3 (0.63) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 | |
| SCHEMBL12672951 | 1.00 | SLC16A3 (0.63) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 | |
| SCHEMBL12672948 | 1.00 | SLC16A3 (0.63) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 | |
| SCHEMBL10059202 | 0.95 | MAPT (0.62) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 | |
| SCHEMBL15431231 | 0.95 | MAPT (0.62) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 | |
| SCHEMBL7006818 | 0.95 | MAPT (0.62) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 | |
| SCHEMBL14856649 | 0.95 | SLC16A3 (0.58) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 | |
| SCHEMBL14773283 | 0.95 | SLC16A3 (0.58) | SLC16A3SLC16A1CISD1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3841361-B1 | POLYMER-COATED HIGH-INDEX WAVEGUIDE FOR ACOUSTIC SENSING | TECHNION RES & DEV FOUNDATION (IL) | 2025-11-19 | — | — | EP | claimed |
| US-11619543-B2 | Polymer-coated high-index waveguide for acoustic sensing | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2023-04-04 | — | — | US | claimed |
| US-20160168083-A1 | THERAPEUTIC COMPOUNDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2016-06-16 | — | — | US | claimed |
| US-20140371272-A1 | THERAPEUTIC COMPOUNDS | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2014-12-18 | — | — | US | claimed |
| EP-2804852-A2 | THERAPEUTIC COMPOUNDS | Regents Of The University Of Minnesota (US) | 2014-11-26 | — | — | EP | claimed |
| WO-2013109972-A2 | THERAPEUTIC COMPOUNDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2013-07-25 | — | — | WO | claimed |
| US-20260104301-A1 | PHYSICAL QUANTITY DETECTION DEVICE | HITACHI ASTEMO, LTD. (JP) | 2026-04-16 | — | — | US | disclosed |
| US-12561356-B2 | Non-transitory computer-readable recording medium storing information processing program, information processing method, and information processing apparatus | FUJITSU LIMITED (JP) | 2026-02-24 | — | — | US | disclosed |
| CN-121342834-A | TB derivative with photodynamic antibacterial and antitumor activities and synthesis method thereof | 江苏师范大学 | 2026-01-16 | — | — | CN | disclosed |
| EP-3841361-B1 | POLYMER-COATED HIGH-INDEX WAVEGUIDE FOR ACOUSTIC SENSING | TECHNION RES & DEV FOUNDATION (IL) | 2025-11-19 | — | — | EP | disclosed |
| US-20250345860-A1 | COATED CUTTING TOOL | WALTER AG (DE) | 2025-11-13 | — | — | US | disclosed |
| US-12421552-B2 | MicroRNA-134 biomarker | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2025-09-23 | — | — | US | disclosed |
| US-12410090-B2 | Non-iox glasses with high coefficient of thermal expansion and preferential fracture behavior for thermal tempering | CORNING INCORPORATED (US) | 2025-09-09 | — | — | US | disclosed |
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090044857-A1 | Dye-Sensitized Photoelectric Conversion Device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20090044857-A1 | Dye-Sensitized Photoelectric Conversion Device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20090032105-A1 | Electrolyte Composition for Photoelectric Converter and Photoelectric Converter Using Same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20080110497-A1 | Modified Titanium Oxide Microparticle and Photoelectric Transducer Making Use of the Same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2008-05-15 | — | — | US | disclosed |
| EP-1885015-A1 | DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE | Nippon Kayaku Kabushiki Kaisha (JP) | 2008-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140371272-A1 | THERAPEUTIC COMPOUNDS | HLA-DRB1, SLC10A1, NFATC1 | SLC16A3 2554/4885SLC16A1 1312/4885CISD1 2317/4885 |
| US-12561356-B2 | Non-transitory computer-readable recording medium storing information processing program, information processing method, and information processing apparatus | TRRAP, VCP, NUDT21 | SLC16A3 1395/4885SLC16A1 898/4885CISD1 3157/4885 |
| US-20090044857-A1 | Dye-Sensitized Photoelectric Conversion Device | CRY1, H1-5, CHRM1 | SLC16A3 2466/4885SLC16A1 2210/4885CISD1 325/4885 |
| US-20160168083-A1 | THERAPEUTIC COMPOUNDS | HLA-DRB1, SLC10A1, NFATC1 | SLC16A3 2283/4885SLC16A1 994/4885CISD1 2126/4885 |
| US-20260104301-A1 | PHYSICAL QUANTITY DETECTION DEVICE | TNNC1, GRK5, TCERG1 | SLC16A3 3640/4885SLC16A1 3544/4885CISD1 4654/4885 |
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | CRY1, H1-5, H1-0 | SLC16A3 2141/4885SLC16A1 1538/4885CISD1 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.